Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01097577 · ClinicalTrials.gov registry record · NA

A Comparison of Pregabalin (Lyrica®) to Placebo in Pain Relief After Photorefractive Keratectomy (PRK) Surgery

A NA study of Postoperative Pain, sponsored by 59th Medical Wing.

Completed
Registry status
NA
Development phase
130
Enrollment target
1
Study location

NCT01097577 is a NA study of Postoperative Pain that has completed, run by 59th Medical Wing. The registered enrollment target is 130 participants, below the 229-participant average among 63 other Postoperative Pain trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01097577, a NA study of Postoperative Pain, has completed, sponsored by 59th Medical Wing.

COMPLETED
Registry status
NA
Development phase
130 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the efficacy of pregabalin to placebo for postoperative pain control after photorefractive keratectomy.

Conditions Studied

Interventions

  • DRUG Placebo
  • DRUG pregabalin

Study Locations (1)

Texas

  • Wilford Hall Medical Center - Refractive Surgery Center - Lackland Air Force Base

Trial Details

FieldValue
Enrollment Target 130 participants
Start Date 2010-03
Est. Completion 2010-06
Phase NA

Sponsor

59th Medical Wing

20 total trials

What the Registry Record Tells You About NCT01097577

The ClinicalTrials.gov registry entry for NCT01097577 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 229-participant average among 63 other Postoperative Pain trials with a reported enrollment target (43% lower). The listed sponsor is 59th Medical Wing, which has 20 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Postoperative Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT01097577 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT01097577 about?

NCT01097577 is a clinical study titled "A Comparison of Pregabalin (Lyrica®) to Placebo in Pain Relief After Photorefractive Keratectomy (PRK) Surgery". The purpose of this study is to compare the efficacy of pregabalin to placebo for postoperative pain control after photorefractive keratectomy.

What is the current status of trial NCT01097577?

This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2010-03. Estimated completion is 2010-06.

What conditions does trial NCT01097577 study?

This clinical trial studies the following conditions: Postoperative Pain.

What interventions are being tested in trial NCT01097577?

The interventions under investigation include: Placebo (DRUG), pregabalin (DRUG).

Who is sponsoring clinical trial NCT01097577?

This trial is sponsored by 59th Medical Wing, which has 20 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01097577 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postoperative Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.